<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36681556</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-9133</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi</Title><ISOAbbreviation>J Microbiol Immunol Infect</ISOAbbreviation></Journal><ArticleTitle>Impact of multiplex polymerase chain reaction syndromic panel on antibiotic use among hospitalized children with respiratory tract illness during COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>688</StartPage><EndPage>694</EndPage><MedlinePgn>688-694</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmii.2023.01.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1684-1182(23)00009-9</ELocationID><Abstract><AbstractText Label="BACKGROUND/PURPOSE" NlmCategory="OBJECTIVE">Precise detection of respiratory pathogens by molecular method potentially may shorten the time to diagnose and reduce unnecessary antibiotic use.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Medical records of hospitalized children from January 2020 to June 2021 with acute respiratory illness who received a FilmArray RP for respiratory pathogens were reviewed and compared with data from diagnosis-matched patients without receiving the test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 283 patients and 150 diagnosis-matched controls were included. Single pathogen was detected in 84.3% (193/229) of the patients. The most common pathogen was human rhinovirus/enterovirus (31.6%, 84/266), followed by respiratory syncytial virus (18.8%, 50/266) and adenovirus (15%, 40/266). Although antimicrobial days of therapy (DOT) was significantly longer in FilmArray group than the control [7.1&#xa0;&#xb1;&#xa0;4.9 days vs 5.7&#xa0;&#xb1;&#xa0;2.7 days, P&#xa0;=&#xa0;0.002], the former showed a higher intensive care unit (ICU) admission rate (3.9% vs 0%; P&#xa0;=&#xa0;0.010). All ICU admissions were in FilmArray RP-positive group. There was no difference in antimicrobial DOT between FilmArray RP-positive and the negative groups, in all admissions, even after excluding ICU admissions. Antimicrobial DOT was shorter in the positive than negative group in patients with lower respiratory tract infections without admission to ICU [median (IQR): 6 (4-9) days vs 9 (4-12) days, P&#xa0;=&#xa0;0.047].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Shorter antimicrobial DOTs were identified in children with lower respiratory tract infection admitted to general pediatric ward and with an identifiable respiratory pathogen, indicating a role of the multiplex PCR in reducing antimicrobial use for children with respiratory tract infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tiew</LastName><ForeName>Wah-Tin</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan; Division of Pediatric Infectious Diseases, Ministry of Health, Putrajaya, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yi-Ching</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Hsuan-Ling</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chyi-Liang</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan; Department of Microbiology and Immunology, College of Medicine, School of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address: dinoschen@adm.cgmh.org.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chih-Jung</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan; Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan. Electronic address: chinjung@adm.cgmh.org.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Cheng-Hsun</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan; Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan. Electronic address: chchiu@adm.cgmh.org.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Microbiol Immunol Infect</MedlineTA><NlmUniqueID>100956211</NlmUniqueID><ISSNLinking>1684-1182</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060885" MajorTopicYN="N">Multiplex Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002673" MajorTopicYN="N">Child, Hospitalized</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012137" MajorTopicYN="N">Respiratory System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000890" MajorTopicYN="Y">Anti-Infective Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antimicrobial</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">DOT</Keyword><Keyword MajorTopicYN="N">Multiplex PCR</Keyword><Keyword MajorTopicYN="N">Respiratory pathogens</Keyword></KeywordList><CoiStatement>Declaration of competing interest All authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36681556</ArticleId><ArticleId IdType="pmc">PMC9841733</ArticleId><ArticleId IdType="doi">10.1016/j.jmii.2023.01.009</ArticleId><ArticleId IdType="pii">S1684-1182(23)00009-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McAllister D.A., Liu L., Shi T., Chu Y., Reed C., Burrows J., et al. Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Global Health. 2019;7:e47&#x2013;e57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6293057</ArticleId><ArticleId IdType="pubmed">30497986</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Li Y., O'Brien K.L., Madhi S.A., Widdowson M.A., Byass P., et al. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study. Lancet Global Health. 2020;8:e497&#x2013;e510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7083228</ArticleId><ArticleId IdType="pubmed">32087815</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings L.C., Anderson T.P., Werno A.M., Beynon K.A., Murdoch D.R. Viral etiology of acute respiratory tract infections in children presenting to hospital: role of polymerase chain reaction and demonstration of multiple infections. Pediatr Infect Dis J. 2004;3:1003&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">15545854</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishaupt J.O., van der Ploeg T., de Groot R., Versteegh F.G.A., Hartwig N.G. Single- and multiple viral respiratory infections in children: disease and management cannot be related to a specific pathogen. BMC Infect Dis. 2017;17:62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5225597</ArticleId><ArticleId IdType="pubmed">28077074</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Ten threats to global health in 2019. 2019. https://www.who.int/news-room/feature-stories/ten-threats-to-global-health-in-2019 Assessed.</Citation></Reference><Reference><Citation>Klein E.Y., Van Boeckel T.P., Martinez E.M., Pant S., Gandra S., Levin S.A., et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115 &#x2012;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899442</ArticleId><ArticleId IdType="pubmed">29581252</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization WHO model list of essential medicines: WHO AWaRe classification database of antibiotics. 2019. https://www.who.int/medicines/publications/essentialmedicines/en Assessed.</Citation></Reference><Reference><Citation>Allwell-Brown G., Hussain-Alkhateeb L., Str&#xf6;mdahl S., M&#xe5;rtensson A., Johansson E.W. Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005-17: a systematic analysis of 132 national surveys from 73 countries. Lancet Global Health. 2020;8:e799&#x2013;e807.</Citation><ArticleIdList><ArticleId IdType="pubmed">32446345</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C., Hsia Y., Bielicki J.A., Ellis S., Stephens P., Wong I.C.K., et al. Estimating global trends in total and childhood and antibiotic consumptioms, 2011-2015. BMJ Global Health. 2019;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6407570</ArticleId><ArticleId IdType="pubmed">30899565</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen L., Schuez-Havupalo L., Karppinen S., Waris M., Hoffman K.L., Camargo C.A., et al. Antibiotic treatments during infancy, changes in nasal microbiota, and asthma development: population-based cohort study. Clin Infect Dis. 2021;72:1546&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8096219</ArticleId><ArticleId IdType="pubmed">32170305</ArticleId></ArticleIdList></Reference><Reference><Citation>Donovan B.M., Abreo A., Ding T., Gebretsadik T., Turi K.N., Yu C., et al. Dose, timing, and type of infant antibiotic use and the risk of childhood asthma. Clin Infect Dis. 2020;70:1658&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145998</ArticleId><ArticleId IdType="pubmed">31149702</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao X., Ding X., Wang B., Li L., An X., Yao Q., et al. Antibiotic exposure in early life increases risk of childhood obesity: a systematic review and meta-analysis. Front Endocrinol. 2017;8:170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5517403</ArticleId><ArticleId IdType="pubmed">28775712</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson K.E., Azar M.M., Banerjee R., Chou A., Colgrove R.C., Ginocchio C.C., et al. Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA's Diagnostics Committee. Clin Infect Dis. 2020;71:2744&#x2013;2751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454374</ArticleId><ArticleId IdType="pubmed">32369578</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumkow L.E., Worden L.J., Rao S.N. Syndromic diagnostic testing: a new way to approach patient care in the treatment of infectious diseases. J Antimicrob Chemother. 2021;76 iii4&#x2012;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460095</ArticleId><ArticleId IdType="pubmed">34555157</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford B.J., So M., Raybardhan S., Leung V., Soucy J.P.R., Westwood D., et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27:520&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785281</ArticleId><ArticleId IdType="pubmed">33418017</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Parra J., Mui&#xf1;o-Miguez A., Bendala-Estrada A.D., Ramos-Mart&#xed;nez A., Mu&#xf1;ez-Rubio E., Carracedo E.F., et al. Inappropriate antibiotic use in the COVID-19 era: factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112666</ArticleId><ArticleId IdType="pubmed">33974637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitano T., Brown K.A., Daneman N., MacFadden D.R., Langford B.J., Leung V., et al. The impact of COVID-19 on outpatient antibiotic prescriptions in Ontario, Canada; an interrupted time series analysis. Open Forum Infect Dis. 2021;8 ofab533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8601042</ArticleId><ArticleId IdType="pubmed">34805442</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarrington M.E., Moehring R.W. Basic, advanced, and novel metrics to guide antibiotic use assessments. Curr Treat Options Infect Dis. 2019;11:145&#x2013;160.</Citation></Reference><Reference><Citation>Man W.H., van Houten M.A., M&#xe9;relle M.E., Vlieger A.M., Chu M.L.J.N., Jansen N.J.G., et al. Bacterial and viral respiratory tract microbiota and host characteristics in children with lower respiratory tract infections: a matched case-control study. Lancet Respir Med. 2019;7:417&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172745</ArticleId><ArticleId IdType="pubmed">30885620</ArticleId></ArticleIdList></Reference><Reference><Citation>Manatrey-Lancaster J.J., Bushman A.M., Caligiuri M.E., Rosa R. Impact of BioFire FilmArray respiratory panel results on antibiotic days of therapy in different clinical settings. Antimicrob Steward Healthcar Epidemiol. 2021;1:e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9495546</ArticleId><ArticleId IdType="pubmed">36168499</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lamb M.M., Moss A., Mistry R.D., Grice K., Ahmed W., et al. Effect of rapid respiratory virus testing on antibiotic prescribing among children presenting to the emergency department with acute respiratory illness: a randomized clinical trial. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8178728</ArticleId><ArticleId IdType="pubmed">34086034</ArticleId></ArticleIdList></Reference><Reference><Citation>Uyeki T.M., Bernstein H.H., Bradley J.S., Englund J.A., File T.M., Fry A.M., et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis. 2019;68:e1&#x2013;e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6653685</ArticleId><ArticleId IdType="pubmed">30566567</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans S.E., Jennerich A.L., Azar M.M., Cao B., Crothers K., Dickson R.P., et al. Nucleic acid-based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2021;203:1070&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8314899</ArticleId><ArticleId IdType="pubmed">33929301</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida K., Hatachi T., Okamoto Y., Aoki Y., Kyogoku M., Miyashita K.M., et al. Application of multiplex polymerase chain reaction for pathogen identification and antibiotic use in children with respiratory infections in a PICU. Pediatr Crit Care Med. 2021;22:e644&#x2013;e648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34224509</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandolfo A.M., Horne R., Jani Y., Reader T.W., Bidad N., Brealey D., et al. Intensivists' beliefs about rapid multiplex molecular diagnostic testing and its potential role in improving prescribing decisions and antimicrobial stewardship: a qualitative study. Antimicrob Resist Infect Control. 2021;10:95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8243627</ArticleId><ArticleId IdType="pubmed">34187563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan W.Y., Thoon K.C., Loo L.H., Chan K.S., Oon L.L.E., Ramasamy A., et al. Trends in respiratory virus infections during the COVID-19 pandemic in Singapore. JAMA Netw Open 2021. 2020;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239970</ArticleId><ArticleId IdType="pubmed">34181015</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q.S., Wood T., Jelley L., Jennings T., Jefferies S., Daniells K., et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12:1001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881137</ArticleId><ArticleId IdType="pubmed">33579926</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>